nodes	percent_of_prediction	percent_of_DWPC	metapath
Mometasone—Hyperadrenocorticism—Temozolomide—melanoma	0.0602	0.0675	CcSEcCtD
Mometasone—Skin striae—Bleomycin—melanoma	0.0347	0.0389	CcSEcCtD
Mometasone—Folliculitis—Vemurafenib—melanoma	0.029	0.0325	CcSEcCtD
Mometasone—Trauma—Bleomycin—melanoma	0.0232	0.026	CcSEcCtD
Mometasone—Impaired healing—Carmustine—melanoma	0.0223	0.025	CcSEcCtD
Mometasone—Musculoskeletal pain—Vemurafenib—melanoma	0.0184	0.0207	CcSEcCtD
Mometasone—Folliculitis—Dactinomycin—melanoma	0.0164	0.0184	CcSEcCtD
Mometasone—Oral candidiasis—Carmustine—melanoma	0.0152	0.017	CcSEcCtD
Mometasone—Oral candidiasis—Temozolomide—melanoma	0.0147	0.0164	CcSEcCtD
Mometasone—Influenza-like symptoms—Temozolomide—melanoma	0.013	0.0146	CcSEcCtD
Mometasone—Otitis media—Temozolomide—melanoma	0.012	0.0134	CcSEcCtD
Mometasone—Ulcer—Bleomycin—melanoma	0.0117	0.0131	CcSEcCtD
Mometasone—Endocrine disorder—Temozolomide—melanoma	0.0112	0.0126	CcSEcCtD
Mometasone—Ulcer—Dactinomycin—melanoma	0.0109	0.0122	CcSEcCtD
Mometasone—Wheezing—Bleomycin—melanoma	0.0107	0.012	CcSEcCtD
Mometasone—Viral infection—Temozolomide—melanoma	0.0103	0.0116	CcSEcCtD
Mometasone—Oral candidiasis—Docetaxel—melanoma	0.00974	0.0109	CcSEcCtD
Mometasone—Musculoskeletal pain—Temozolomide—melanoma	0.00942	0.0106	CcSEcCtD
Mometasone—Candida infection—Carmustine—melanoma	0.00919	0.0103	CcSEcCtD
Mometasone—Influenza like illness—Temozolomide—melanoma	0.00904	0.0101	CcSEcCtD
Mometasone—Candida infection—Temozolomide—melanoma	0.00889	0.00996	CcSEcCtD
Mometasone—Injury—Bleomycin—melanoma	0.00871	0.00977	CcSEcCtD
Mometasone—Mediastinal disorder—Vemurafenib—melanoma	0.00824	0.00924	CcSEcCtD
Mometasone—Otitis media—Docetaxel—melanoma	0.00795	0.00891	CcSEcCtD
Mometasone—Ear pain—Temozolomide—melanoma	0.00792	0.00888	CcSEcCtD
Mometasone—Back pain—Vemurafenib—melanoma	0.0077	0.00863	CcSEcCtD
Mometasone—Gastroenteritis—Temozolomide—melanoma	0.00762	0.00855	CcSEcCtD
Mometasone—Injury—Carmustine—melanoma	0.00761	0.00853	CcSEcCtD
Mometasone—Nasal congestion—Temozolomide—melanoma	0.00742	0.00831	CcSEcCtD
Mometasone—Cough—Vemurafenib—melanoma	0.00695	0.00779	CcSEcCtD
Mometasone—Bronchospasm—Bleomycin—melanoma	0.00681	0.00763	CcSEcCtD
Mometasone—Arthralgia—Vemurafenib—melanoma	0.00678	0.0076	CcSEcCtD
Mometasone—Myalgia—Vemurafenib—melanoma	0.00678	0.0076	CcSEcCtD
Mometasone—NR3C1—FOXA2 and FOXA3 transcription factor networks—CPT1C—melanoma	0.00665	0.0725	CbGpPWpGaD
Mometasone—Anaphylactic shock—Vemurafenib—melanoma	0.0065	0.00728	CcSEcCtD
Mometasone—Infection—Vemurafenib—melanoma	0.00645	0.00724	CcSEcCtD
Mometasone—Influenza like illness—Docetaxel—melanoma	0.00601	0.00674	CcSEcCtD
Mometasone—Musculoskeletal discomfort—Vemurafenib—melanoma	0.00592	0.00664	CcSEcCtD
Mometasone—Candida infection—Docetaxel—melanoma	0.00591	0.00662	CcSEcCtD
Mometasone—Decreased appetite—Vemurafenib—melanoma	0.00565	0.00633	CcSEcCtD
Mometasone—Bronchitis—Temozolomide—melanoma	0.00562	0.0063	CcSEcCtD
Mometasone—Fatigue—Vemurafenib—melanoma	0.0056	0.00628	CcSEcCtD
Mometasone—Upper respiratory tract infection—Temozolomide—melanoma	0.00543	0.00608	CcSEcCtD
Mometasone—Urinary tract infection—Carmustine—melanoma	0.00524	0.00587	CcSEcCtD
Mometasone—Body temperature increased—Vemurafenib—melanoma	0.00514	0.00576	CcSEcCtD
Mometasone—Pharyngitis—Dactinomycin—melanoma	0.00513	0.00575	CcSEcCtD
Mometasone—Urinary tract infection—Temozolomide—melanoma	0.00506	0.00567	CcSEcCtD
Mometasone—Sinusitis—Temozolomide—melanoma	0.00488	0.00548	CcSEcCtD
Mometasone—NR3C1—Regulation of Androgen receptor activity—HOXB13—melanoma	0.00487	0.0531	CbGpPWpGaD
Mometasone—Asthenia—Vemurafenib—melanoma	0.00466	0.00523	CcSEcCtD
Mometasone—Pharyngitis—Temozolomide—melanoma	0.00464	0.0052	CcSEcCtD
Mometasone—Pruritus—Vemurafenib—melanoma	0.0046	0.00515	CcSEcCtD
Mometasone—Diarrhoea—Vemurafenib—melanoma	0.00445	0.00498	CcSEcCtD
Mometasone—Immune system disorder—Temozolomide—melanoma	0.00422	0.00473	CcSEcCtD
Mometasone—Mediastinal disorder—Temozolomide—melanoma	0.00421	0.00472	CcSEcCtD
Mometasone—Cough—Bleomycin—melanoma	0.00421	0.00472	CcSEcCtD
Mometasone—Vomiting—Vemurafenib—melanoma	0.00413	0.00463	CcSEcCtD
Mometasone—Chest pain—Bleomycin—melanoma	0.00411	0.0046	CcSEcCtD
Mometasone—Myalgia—Bleomycin—melanoma	0.00411	0.0046	CcSEcCtD
Mometasone—Rash—Vemurafenib—melanoma	0.0041	0.00459	CcSEcCtD
Mometasone—Dermatitis—Vemurafenib—melanoma	0.00409	0.00459	CcSEcCtD
Mometasone—Back pain—Carmustine—melanoma	0.00407	0.00457	CcSEcCtD
Mometasone—Headache—Vemurafenib—melanoma	0.00407	0.00456	CcSEcCtD
Mometasone—Nasopharyngitis—Docetaxel—melanoma	0.00402	0.0045	CcSEcCtD
Mometasone—Anaphylactic shock—Bleomycin—melanoma	0.00394	0.00441	CcSEcCtD
Mometasone—Back pain—Temozolomide—melanoma	0.00394	0.00441	CcSEcCtD
Mometasone—Infection—Bleomycin—melanoma	0.00391	0.00438	CcSEcCtD
Mometasone—Nausea—Vemurafenib—melanoma	0.00386	0.00433	CcSEcCtD
Mometasone—Myalgia—Dactinomycin—melanoma	0.00383	0.00429	CcSEcCtD
Mometasone—Bronchospasm—Docetaxel—melanoma	0.00382	0.00428	CcSEcCtD
Mometasone—Anorexia—Bleomycin—melanoma	0.00375	0.00421	CcSEcCtD
Mometasone—Angioedema—Temozolomide—melanoma	0.00372	0.00417	CcSEcCtD
Mometasone—Infection—Dactinomycin—melanoma	0.00365	0.00409	CcSEcCtD
Mometasone—Musculoskeletal discomfort—Bleomycin—melanoma	0.00359	0.00402	CcSEcCtD
Mometasone—Chest pain—Carmustine—melanoma	0.00358	0.00402	CcSEcCtD
Mometasone—Myalgia—Carmustine—melanoma	0.00358	0.00402	CcSEcCtD
Mometasone—Cough—Temozolomide—melanoma	0.00355	0.00398	CcSEcCtD
Mometasone—Paraesthesia—Bleomycin—melanoma	0.00353	0.00396	CcSEcCtD
Mometasone—Dyspnoea—Bleomycin—melanoma	0.00351	0.00393	CcSEcCtD
Mometasone—Anorexia—Dactinomycin—melanoma	0.0035	0.00392	CcSEcCtD
Mometasone—Arthralgia—Temozolomide—melanoma	0.00346	0.00388	CcSEcCtD
Mometasone—Myalgia—Temozolomide—melanoma	0.00346	0.00388	CcSEcCtD
Mometasone—Decreased appetite—Bleomycin—melanoma	0.00342	0.00384	CcSEcCtD
Mometasone—Infection—Carmustine—melanoma	0.00341	0.00383	CcSEcCtD
Mometasone—Dry mouth—Temozolomide—melanoma	0.00339	0.0038	CcSEcCtD
Mometasone—Pain—Bleomycin—melanoma	0.00337	0.00377	CcSEcCtD
Mometasone—Conjunctivitis—Docetaxel—melanoma	0.00337	0.00377	CcSEcCtD
Mometasone—Musculoskeletal discomfort—Dactinomycin—melanoma	0.00334	0.00375	CcSEcCtD
Mometasone—Anaphylactic shock—Temozolomide—melanoma	0.00332	0.00372	CcSEcCtD
Mometasone—Infection—Temozolomide—melanoma	0.0033	0.0037	CcSEcCtD
Mometasone—Anorexia—Carmustine—melanoma	0.00328	0.00367	CcSEcCtD
Mometasone—Epistaxis—Docetaxel—melanoma	0.00327	0.00366	CcSEcCtD
Mometasone—Decreased appetite—Dactinomycin—melanoma	0.00319	0.00358	CcSEcCtD
Mometasone—Fatigue—Dactinomycin—melanoma	0.00317	0.00355	CcSEcCtD
Mometasone—Anorexia—Temozolomide—melanoma	0.00317	0.00355	CcSEcCtD
Mometasone—Pain—Dactinomycin—melanoma	0.00314	0.00352	CcSEcCtD
Mometasone—Musculoskeletal discomfort—Carmustine—melanoma	0.00313	0.00351	CcSEcCtD
Mometasone—CYP2C8—Synthesis of epoxy (EET) and dihydroxyeicosatrienoic acids (DHET)—CYP1B1—melanoma	0.00312	0.034	CbGpPWpGaD
Mometasone—Rhinitis—Docetaxel—melanoma	0.00312	0.00349	CcSEcCtD
Mometasone—Body temperature increased—Bleomycin—melanoma	0.00311	0.00349	CcSEcCtD
Mometasone—Paraesthesia—Carmustine—melanoma	0.00309	0.00346	CcSEcCtD
Mometasone—Pharyngitis—Docetaxel—melanoma	0.00308	0.00346	CcSEcCtD
Mometasone—Dyspnoea—Carmustine—melanoma	0.00306	0.00343	CcSEcCtD
Mometasone—Musculoskeletal discomfort—Temozolomide—melanoma	0.00303	0.00339	CcSEcCtD
Mometasone—Gastrointestinal pain—Dactinomycin—melanoma	0.003	0.00337	CcSEcCtD
Mometasone—Decreased appetite—Carmustine—melanoma	0.00299	0.00335	CcSEcCtD
Mometasone—Paraesthesia—Temozolomide—melanoma	0.00298	0.00334	CcSEcCtD
Mometasone—Dyspnoea—Temozolomide—melanoma	0.00296	0.00332	CcSEcCtD
Mometasone—Pain—Carmustine—melanoma	0.00294	0.00329	CcSEcCtD
Mometasone—Dyspepsia—Temozolomide—melanoma	0.00292	0.00328	CcSEcCtD
Mometasone—Abdominal pain—Dactinomycin—melanoma	0.0029	0.00325	CcSEcCtD
Mometasone—Body temperature increased—Dactinomycin—melanoma	0.0029	0.00325	CcSEcCtD
Mometasone—Decreased appetite—Temozolomide—melanoma	0.00289	0.00324	CcSEcCtD
Mometasone—Fatigue—Temozolomide—melanoma	0.00286	0.00321	CcSEcCtD
Mometasone—Pain—Temozolomide—melanoma	0.00284	0.00318	CcSEcCtD
Mometasone—CYP2C8—Synthesis of (16-20)-hydroxyeicosatetraenoic acids (HETE)—CYP1B1—melanoma	0.00284	0.0309	CbGpPWpGaD
Mometasone—Asthenia—Bleomycin—melanoma	0.00282	0.00317	CcSEcCtD
Mometasone—Gastrointestinal pain—Carmustine—melanoma	0.00281	0.00315	CcSEcCtD
Mometasone—Immune system disorder—Docetaxel—melanoma	0.00281	0.00315	CcSEcCtD
Mometasone—Mediastinal disorder—Docetaxel—melanoma	0.0028	0.00314	CcSEcCtD
Mometasone—Pruritus—Bleomycin—melanoma	0.00278	0.00312	CcSEcCtD
Mometasone—Abdominal pain—Carmustine—melanoma	0.00272	0.00305	CcSEcCtD
Mometasone—Body temperature increased—Carmustine—melanoma	0.00272	0.00305	CcSEcCtD
Mometasone—Gastrointestinal pain—Temozolomide—melanoma	0.00272	0.00304	CcSEcCtD
Mometasone—Asthenia—Dactinomycin—melanoma	0.00263	0.00295	CcSEcCtD
Mometasone—Abdominal pain—Temozolomide—melanoma	0.00262	0.00294	CcSEcCtD
Mometasone—Body temperature increased—Temozolomide—melanoma	0.00262	0.00294	CcSEcCtD
Mometasone—Back pain—Docetaxel—melanoma	0.00262	0.00293	CcSEcCtD
Mometasone—Diarrhoea—Dactinomycin—melanoma	0.00251	0.00282	CcSEcCtD
Mometasone—Vomiting—Bleomycin—melanoma	0.0025	0.00281	CcSEcCtD
Mometasone—Rash—Bleomycin—melanoma	0.00248	0.00278	CcSEcCtD
Mometasone—Dermatitis—Bleomycin—melanoma	0.00248	0.00278	CcSEcCtD
Mometasone—Asthenia—Carmustine—melanoma	0.00247	0.00276	CcSEcCtD
Mometasone—Dexamethasone—CYP17A1—melanoma	0.00245	0.15	CrCbGaD
Mometasone—Asthenia—Temozolomide—melanoma	0.00238	0.00267	CcSEcCtD
Mometasone—Cough—Docetaxel—melanoma	0.00236	0.00265	CcSEcCtD
Mometasone—Diarrhoea—Carmustine—melanoma	0.00235	0.00264	CcSEcCtD
Mometasone—Pruritus—Temozolomide—melanoma	0.00235	0.00263	CcSEcCtD
Mometasone—Nausea—Bleomycin—melanoma	0.00234	0.00262	CcSEcCtD
Mometasone—Vomiting—Dactinomycin—melanoma	0.00233	0.00262	CcSEcCtD
Mometasone—Rash—Dactinomycin—melanoma	0.00231	0.0026	CcSEcCtD
Mometasone—Myalgia—Docetaxel—melanoma	0.0023	0.00258	CcSEcCtD
Mometasone—Chest pain—Docetaxel—melanoma	0.0023	0.00258	CcSEcCtD
Mometasone—Arthralgia—Docetaxel—melanoma	0.0023	0.00258	CcSEcCtD
Mometasone—Diarrhoea—Temozolomide—melanoma	0.00227	0.00255	CcSEcCtD
Mometasone—Dry mouth—Docetaxel—melanoma	0.00225	0.00253	CcSEcCtD
Mometasone—NR3C1—Signaling events mediated by HDAC Class II—HDAC6—melanoma	0.00221	0.0241	CbGpPWpGaD
Mometasone—Anaphylactic shock—Docetaxel—melanoma	0.00221	0.00248	CcSEcCtD
Mometasone—Infection—Docetaxel—melanoma	0.00219	0.00246	CcSEcCtD
Mometasone—Vomiting—Carmustine—melanoma	0.00218	0.00245	CcSEcCtD
Mometasone—Nausea—Dactinomycin—melanoma	0.00218	0.00244	CcSEcCtD
Mometasone—Rash—Carmustine—melanoma	0.00217	0.00243	CcSEcCtD
Mometasone—Dermatitis—Carmustine—melanoma	0.00216	0.00243	CcSEcCtD
Mometasone—Headache—Carmustine—melanoma	0.00215	0.00241	CcSEcCtD
Mometasone—NR3C1—Adipogenesis—ASIP—melanoma	0.00212	0.0231	CbGpPWpGaD
Mometasone—Vomiting—Temozolomide—melanoma	0.00211	0.00237	CcSEcCtD
Mometasone—Anorexia—Docetaxel—melanoma	0.0021	0.00236	CcSEcCtD
Mometasone—Rash—Temozolomide—melanoma	0.00209	0.00235	CcSEcCtD
Mometasone—Dermatitis—Temozolomide—melanoma	0.00209	0.00235	CcSEcCtD
Mometasone—Headache—Temozolomide—melanoma	0.00208	0.00233	CcSEcCtD
Mometasone—Nausea—Carmustine—melanoma	0.00204	0.00229	CcSEcCtD
Mometasone—Musculoskeletal discomfort—Docetaxel—melanoma	0.00201	0.00226	CcSEcCtD
Mometasone—Dexamethasone—NOS2—melanoma	0.00199	0.122	CrCbGaD
Mometasone—Paraesthesia—Docetaxel—melanoma	0.00198	0.00222	CcSEcCtD
Mometasone—Nausea—Temozolomide—melanoma	0.00197	0.00221	CcSEcCtD
Mometasone—Dyspnoea—Docetaxel—melanoma	0.00197	0.00221	CcSEcCtD
Mometasone—Dyspepsia—Docetaxel—melanoma	0.00194	0.00218	CcSEcCtD
Mometasone—Decreased appetite—Docetaxel—melanoma	0.00192	0.00215	CcSEcCtD
Mometasone—Fatigue—Docetaxel—melanoma	0.0019	0.00213	CcSEcCtD
Mometasone—Pain—Docetaxel—melanoma	0.00189	0.00212	CcSEcCtD
Mometasone—NR3C1—Serotonin Receptor 4/6/7 and NR3C Signaling—MAP2K2—melanoma	0.00187	0.0204	CbGpPWpGaD
Mometasone—NR3C1—SIDS Susceptibility Pathways—POU3F2—melanoma	0.00183	0.02	CbGpPWpGaD
Mometasone—Gastrointestinal pain—Docetaxel—melanoma	0.00181	0.00202	CcSEcCtD
Mometasone—Body temperature increased—Docetaxel—melanoma	0.00175	0.00196	CcSEcCtD
Mometasone—Abdominal pain—Docetaxel—melanoma	0.00175	0.00196	CcSEcCtD
Mometasone—NR3C1—Endoderm Differentiation—NODAL—melanoma	0.00174	0.0189	CbGpPWpGaD
Mometasone—Dexamethasone—CYP1B1—melanoma	0.00169	0.104	CrCbGaD
Mometasone—Asthenia—Docetaxel—melanoma	0.00158	0.00178	CcSEcCtD
Mometasone—Pruritus—Docetaxel—melanoma	0.00156	0.00175	CcSEcCtD
Mometasone—Fluticasone furoate—ABCB1—melanoma	0.00152	0.0929	CrCbGaD
Mometasone—Diarrhoea—Docetaxel—melanoma	0.00151	0.00169	CcSEcCtD
Mometasone—NR3C1—Regulation of nuclear SMAD2/3 signaling—SKI—melanoma	0.00146	0.0159	CbGpPWpGaD
Mometasone—CYP2C8—Tamoxifen metabolism—CYP1B1—melanoma	0.00144	0.0157	CbGpPWpGaD
Mometasone—NR3C1—AP-1 transcription factor network—BCL2L11—melanoma	0.00141	0.0154	CbGpPWpGaD
Mometasone—NR3C1—Serotonin Receptor 4/6/7 and NR3C Signaling—BRAF—melanoma	0.00141	0.0154	CbGpPWpGaD
Mometasone—Vomiting—Docetaxel—melanoma	0.0014	0.00157	CcSEcCtD
Mometasone—Rash—Docetaxel—melanoma	0.00139	0.00156	CcSEcCtD
Mometasone—Dermatitis—Docetaxel—melanoma	0.00139	0.00156	CcSEcCtD
Mometasone—Headache—Docetaxel—melanoma	0.00138	0.00155	CcSEcCtD
Mometasone—NR3C1—Serotonin Receptor 4/6/7 and NR3C Signaling—MAP2K1—melanoma	0.00133	0.0145	CbGpPWpGaD
Mometasone—Nausea—Docetaxel—melanoma	0.00131	0.00147	CcSEcCtD
Mometasone—NR3C1—Transcription factor regulation in adipogenesis—PPARG—melanoma	0.00129	0.0141	CbGpPWpGaD
Mometasone—NR3C1—AP-1 transcription factor network—NPPA—melanoma	0.00129	0.014	CbGpPWpGaD
Mometasone—Methylprednisolone—ABCB1—melanoma	0.00121	0.0741	CrCbGaD
Mometasone—Triamcinolone—PTGS2—melanoma	0.0012	0.0735	CrCbGaD
Mometasone—NR3C1—Nuclear Receptors—VDR—melanoma	0.00119	0.013	CbGpPWpGaD
Mometasone—NR3C1—AP-1 transcription factor network—ETS1—melanoma	0.00115	0.0125	CbGpPWpGaD
Mometasone—NR3C1—SIDS Susceptibility Pathways—MAP2—melanoma	0.00105	0.0115	CbGpPWpGaD
Mometasone—Betamethasone—PTGS2—melanoma	0.000983	0.0602	CrCbGaD
Mometasone—Prednisone—ALB—melanoma	0.00097	0.0594	CrCbGaD
Mometasone—CYP2C8—Biological oxidations—UGT2B10—melanoma	0.000955	0.0104	CbGpPWpGaD
Mometasone—NR3C1—Nuclear Receptor transcription pathway—VDR—melanoma	0.000944	0.0103	CbGpPWpGaD
Mometasone—Prednisone—ABCB1—melanoma	0.000926	0.0566	CrCbGaD
Mometasone—NR3C1—SIDS Susceptibility Pathways—TP73—melanoma	0.000894	0.00975	CbGpPWpGaD
Mometasone—Prednisolone—ABCB1—melanoma	0.000853	0.0522	CrCbGaD
Mometasone—NR3C1—Serotonin Receptor 4/6/7 and NR3C Signaling—MAPK3—melanoma	0.00085	0.00927	CbGpPWpGaD
Mometasone—NR3C1—Regulation of nuclear SMAD2/3 signaling—FOXO4—melanoma	0.000837	0.00912	CbGpPWpGaD
Mometasone—NR3C1—Regulation of nuclear SMAD2/3 signaling—HDAC2—melanoma	0.000837	0.00912	CbGpPWpGaD
Mometasone—Betamethasone—ABCB1—melanoma	0.000836	0.0512	CrCbGaD
Mometasone—NR3C1—Nuclear Receptors—PPARG—melanoma	0.000833	0.00908	CbGpPWpGaD
Mometasone—NR3C1—Glucocorticoid receptor regulatory network—HDAC2—melanoma	0.000828	0.00904	CbGpPWpGaD
Mometasone—NR3C1—Regulation of nuclear SMAD2/3 signaling—IFNB1—melanoma	0.000821	0.00896	CbGpPWpGaD
Mometasone—NR3C1—Serotonin Receptor 4/6/7 and NR3C Signaling—MAPK1—melanoma	0.000808	0.00882	CbGpPWpGaD
Mometasone—CYP2C8—Cytochrome P450 - arranged by substrate type—CYP17A1—melanoma	0.000739	0.00806	CbGpPWpGaD
Mometasone—CYP2C8—Oxidation by Cytochrome P450—CYP17A1—melanoma	0.000729	0.00795	CbGpPWpGaD
Mometasone—NR3C1—Circadian Clock—HIF1A—melanoma	0.000728	0.00794	CbGpPWpGaD
Mometasone—NR3C1—AP-1 transcription factor network—EDN1—melanoma	0.000721	0.00786	CbGpPWpGaD
Mometasone—CYP2C8—Arachidonic acid metabolism—CYP1B1—melanoma	0.000719	0.00785	CbGpPWpGaD
Mometasone—NR3C1—AP-1 transcription factor network—IL10—melanoma	0.000713	0.00777	CbGpPWpGaD
Mometasone—NR3C1—AP-1 transcription factor network—CSF2—melanoma	0.000705	0.00768	CbGpPWpGaD
Mometasone—NR3C1—AP-1 transcription factor network—IL4—melanoma	0.000693	0.00756	CbGpPWpGaD
Mometasone—NR3C1—Transcription factor regulation in adipogenesis—TNF—melanoma	0.000685	0.00747	CbGpPWpGaD
Mometasone—NR3C1—Regulation of nuclear SMAD2/3 signaling—CDKN2B—melanoma	0.000669	0.00729	CbGpPWpGaD
Mometasone—NR3C1—FOXA2 and FOXA3 transcription factor networks—ALB—melanoma	0.000666	0.00726	CbGpPWpGaD
Mometasone—NR3C1—Nuclear Receptor transcription pathway—PPARG—melanoma	0.000658	0.00718	CbGpPWpGaD
Mometasone—Hydrocortisone—ABCB1—melanoma	0.000653	0.0399	CrCbGaD
Mometasone—NR3C1—Regulation of nuclear SMAD2/3 signaling—VDR—melanoma	0.000652	0.00711	CbGpPWpGaD
Mometasone—NR3C1—Regulation of nuclear SMAD2/3 signaling—IL10—melanoma	0.000634	0.00692	CbGpPWpGaD
Mometasone—NR3C1—AP-1 transcription factor network—HLA-A—melanoma	0.000628	0.00685	CbGpPWpGaD
Mometasone—CYP2C8—Cytochrome P450 - arranged by substrate type—CYP1B1—melanoma	0.000622	0.00678	CbGpPWpGaD
Mometasone—NR3C1—Glucocorticoid receptor regulatory network—CSF2—melanoma	0.000621	0.00677	CbGpPWpGaD
Mometasone—CYP2C8—Oxidation by Cytochrome P450—CYP1B1—melanoma	0.000614	0.00669	CbGpPWpGaD
Mometasone—NR3C1—Glucocorticoid receptor regulatory network—IL4—melanoma	0.000611	0.00666	CbGpPWpGaD
Mometasone—CYP2C8—Metapathway biotransformation—AKR1B10—melanoma	0.000607	0.00662	CbGpPWpGaD
Mometasone—NR3C1—AP-1 transcription factor network—MMP1—melanoma	0.000606	0.00661	CbGpPWpGaD
Mometasone—NR3C1—AP-1 transcription factor network—HIF1A—melanoma	0.000601	0.00655	CbGpPWpGaD
Mometasone—CYP2C8—Phase 1 - Functionalization of compounds—CYP17A1—melanoma	0.000599	0.00653	CbGpPWpGaD
Mometasone—Dexamethasone—PTGS2—melanoma	0.000572	0.035	CrCbGaD
Mometasone—NR3C1—Endoderm Differentiation—NOTCH1—melanoma	0.000554	0.00604	CbGpPWpGaD
Mometasone—NR3C1—Transcription factor regulation in adipogenesis—IL6—melanoma	0.000552	0.00603	CbGpPWpGaD
Mometasone—NR3C1—Endoderm Differentiation—APC—melanoma	0.000542	0.00591	CbGpPWpGaD
Mometasone—NR3C1—Glucocorticoid receptor regulatory network—MMP1—melanoma	0.000534	0.00582	CbGpPWpGaD
Mometasone—NR3C1—Regulation of nuclear SMAD2/3 signaling—CDK2—melanoma	0.000529	0.00577	CbGpPWpGaD
Mometasone—NR3C1—Regulation of Androgen receptor activity—MDM2—melanoma	0.000521	0.00568	CbGpPWpGaD
Mometasone—CYP2C8—Phase 1 - Functionalization of compounds—CYP1B1—melanoma	0.000504	0.0055	CbGpPWpGaD
Mometasone—NR3C1—Regulation of nuclear SMAD2/3 signaling—CDK4—melanoma	0.0005	0.00545	CbGpPWpGaD
Mometasone—Dexamethasone—ABCB1—melanoma	0.000486	0.0298	CrCbGaD
Mometasone—NR3C1—Glucocorticoid receptor regulatory network—ICAM1—melanoma	0.000485	0.00529	CbGpPWpGaD
Mometasone—NR3C1—Adipogenesis—SOCS1—melanoma	0.000484	0.00528	CbGpPWpGaD
Mometasone—NR3C1—AP-1 transcription factor network—CDKN2A—melanoma	0.00043	0.00469	CbGpPWpGaD
Mometasone—NR3C1—Adipogenesis—E2F1—melanoma	0.00042	0.00458	CbGpPWpGaD
Mometasone—NR3C1—AP-1 transcription factor network—IFNG—melanoma	0.000419	0.00457	CbGpPWpGaD
Mometasone—NR3C1—Gene Expression—CLNS1A—melanoma	0.000418	0.00456	CbGpPWpGaD
Mometasone—CYP2C8—Metabolism of lipids and lipoproteins—ACER3—melanoma	0.000401	0.00437	CbGpPWpGaD
Mometasone—NR3C1—AP-1 transcription factor network—CXCL8—melanoma	0.00039	0.00425	CbGpPWpGaD
Mometasone—NR3C1—Adipogenesis—FAS—melanoma	0.000389	0.00425	CbGpPWpGaD
Mometasone—NR3C1—AP-1 transcription factor network—CDKN1B—melanoma	0.000381	0.00415	CbGpPWpGaD
Mometasone—NR3C1—SIDS Susceptibility Pathways—IL10—melanoma	0.000375	0.00409	CbGpPWpGaD
Mometasone—NR3C1—AP-1 transcription factor network—IL2—melanoma	0.000372	0.00406	CbGpPWpGaD
Mometasone—NR3C1—Glucocorticoid receptor regulatory network—IFNG—melanoma	0.000369	0.00403	CbGpPWpGaD
Mometasone—NR3C1—Endoderm Differentiation—CTNNB1—melanoma	0.000368	0.00401	CbGpPWpGaD
Mometasone—NR3C1—Glucocorticoid receptor regulatory network—MDM2—melanoma	0.000367	0.004	CbGpPWpGaD
Mometasone—NR3C1—Adipogenesis—HIF1A—melanoma	0.000366	0.00399	CbGpPWpGaD
Mometasone—NR3C1—Generic Transcription Pathway—SKI—melanoma	0.000366	0.00399	CbGpPWpGaD
Mometasone—NR3C1—AP-1 transcription factor network—CCND1—melanoma	0.000363	0.00396	CbGpPWpGaD
Mometasone—NR3C1—AP-1 transcription factor network—CTNNB1—melanoma	0.000359	0.00392	CbGpPWpGaD
Mometasone—NR3C1—AP-1 transcription factor network—MMP9—melanoma	0.000352	0.00384	CbGpPWpGaD
Mometasone—NR3C1—AP-1 transcription factor network—PTEN—melanoma	0.00035	0.00382	CbGpPWpGaD
Mometasone—NR3C1—Glucocorticoid receptor regulatory network—CXCL8—melanoma	0.000343	0.00374	CbGpPWpGaD
Mometasone—NR3C1—Glucocorticoid receptor regulatory network—IL2—melanoma	0.000328	0.00358	CbGpPWpGaD
Mometasone—CYP2C8—Arachidonic acid metabolism—PTGS2—melanoma	0.000324	0.00354	CbGpPWpGaD
Mometasone—CYP2C8—Biological oxidations—CYP17A1—melanoma	0.000318	0.00347	CbGpPWpGaD
Mometasone—NR3C1—SIDS Susceptibility Pathways—HIF1A—melanoma	0.000316	0.00345	CbGpPWpGaD
Mometasone—CYP2C8—Metapathway biotransformation—CYP17A1—melanoma	0.000314	0.00342	CbGpPWpGaD
Mometasone—NR3C1—Regulation of nuclear SMAD2/3 signaling—CDKN1A—melanoma	0.000312	0.00341	CbGpPWpGaD
Mometasone—NR3C1—Adipogenesis—PPARG—melanoma	0.000311	0.00339	CbGpPWpGaD
Mometasone—NR3C1—Glucocorticoid receptor regulatory network—CDKN1A—melanoma	0.000309	0.00337	CbGpPWpGaD
Mometasone—NR3C1—Glucocorticoid receptor regulatory network—NFKB1—melanoma	0.000307	0.00335	CbGpPWpGaD
Mometasone—NR3C1—Adipogenesis—RB1—melanoma	0.000298	0.00325	CbGpPWpGaD
Mometasone—NR3C1—Adipogenesis—IGF1—melanoma	0.000295	0.00322	CbGpPWpGaD
Mometasone—NR3C1—FOXA2 and FOXA3 transcription factor networks—AKT1—melanoma	0.000293	0.00319	CbGpPWpGaD
Mometasone—NR3C1—AP-1 transcription factor network—MYC—melanoma	0.000291	0.00318	CbGpPWpGaD
Mometasone—NR3C1—Generic Transcription Pathway—NPPA—melanoma	0.000286	0.00312	CbGpPWpGaD
Mometasone—CYP2C8—Biological oxidations—CYP1B1—melanoma	0.000268	0.00292	CbGpPWpGaD
Mometasone—CYP2C8—Metapathway biotransformation—CYP1B1—melanoma	0.000264	0.00288	CbGpPWpGaD
Mometasone—NR3C1—Glucocorticoid receptor regulatory network—MAPK3—melanoma	0.000264	0.00288	CbGpPWpGaD
Mometasone—NR3C1—Regulation of nuclear SMAD2/3 signaling—MYC—melanoma	0.000259	0.00283	CbGpPWpGaD
Mometasone—NR3C1—Glucocorticoid receptor regulatory network—MAPK1—melanoma	0.000251	0.00274	CbGpPWpGaD
Mometasone—CYP2C8—Metabolism of lipids and lipoproteins—PIP4K2A—melanoma	0.000243	0.00265	CbGpPWpGaD
Mometasone—NR3C1—AP-1 transcription factor network—TP53—melanoma	0.000239	0.00261	CbGpPWpGaD
Mometasone—NR3C1—Adipogenesis—CTNNB1—melanoma	0.000219	0.00239	CbGpPWpGaD
Mometasone—NR3C1—AP-1 transcription factor network—IL6—melanoma	0.000219	0.00239	CbGpPWpGaD
Mometasone—NR3C1—Adipogenesis—CDKN1A—melanoma	0.000214	0.00233	CbGpPWpGaD
Mometasone—NR3C1—Glucocorticoid receptor regulatory network—TP53—melanoma	0.000211	0.0023	CbGpPWpGaD
Mometasone—NR3C1—SIDS Susceptibility Pathways—CXCL8—melanoma	0.000205	0.00224	CbGpPWpGaD
Mometasone—CYP2C8—Metabolism of lipids and lipoproteins—CUBN—melanoma	0.000203	0.00221	CbGpPWpGaD
Mometasone—NR3C1—SIDS Susceptibility Pathways—CASP3—melanoma	0.000196	0.00214	CbGpPWpGaD
Mometasone—NR3C1—Glucocorticoid receptor regulatory network—IL6—melanoma	0.000193	0.0021	CbGpPWpGaD
Mometasone—NR3C1—Adipogenesis—STAT3—melanoma	0.000191	0.00208	CbGpPWpGaD
Mometasone—CYP2C8—Metabolism of lipids and lipoproteins—GPAM—melanoma	0.00019	0.00207	CbGpPWpGaD
Mometasone—NR3C1—SIDS Susceptibility Pathways—CTNNB1—melanoma	0.000189	0.00206	CbGpPWpGaD
Mometasone—NR3C1—SIDS Susceptibility Pathways—NFKB1—melanoma	0.000184	0.002	CbGpPWpGaD
Mometasone—NR3C1—Regulation of nuclear SMAD2/3 signaling—AKT1—melanoma	0.00018	0.00196	CbGpPWpGaD
Mometasone—NR3C1—Gene Expression—RPS3—melanoma	0.000179	0.00195	CbGpPWpGaD
Mometasone—CYP2C8—Metabolism—ACER3—melanoma	0.000179	0.00195	CbGpPWpGaD
Mometasone—NR3C1—Glucocorticoid receptor regulatory network—AKT1—melanoma	0.000178	0.00194	CbGpPWpGaD
Mometasone—NR3C1—Gene Expression—SNRPE—melanoma	0.000176	0.00192	CbGpPWpGaD
Mometasone—NR3C1—Gene Expression—SKI—melanoma	0.000176	0.00192	CbGpPWpGaD
Mometasone—NR3C1—Generic Transcription Pathway—CDKN2B—melanoma	0.000167	0.00182	CbGpPWpGaD
Mometasone—NR3C1—SIDS Susceptibility Pathways—VEGFA—melanoma	0.000167	0.00182	CbGpPWpGaD
Mometasone—NR3C1—Adipogenesis—TNF—melanoma	0.000165	0.0018	CbGpPWpGaD
Mometasone—CYP2C8—Metabolism—UGT2B10—melanoma	0.000163	0.00178	CbGpPWpGaD
Mometasone—NR3C1—Generic Transcription Pathway—VDR—melanoma	0.000163	0.00178	CbGpPWpGaD
Mometasone—CYP2C8—Metabolism of lipids and lipoproteins—PLA2G6—melanoma	0.000161	0.00176	CbGpPWpGaD
Mometasone—CYP2C8—Metabolism—HS3ST5—melanoma	0.000152	0.00166	CbGpPWpGaD
Mometasone—NR3C1—SIDS Susceptibility Pathways—TNF—melanoma	0.000143	0.00156	CbGpPWpGaD
Mometasone—NR3C1—Gene Expression—NPPA—melanoma	0.000138	0.0015	CbGpPWpGaD
Mometasone—NR3C1—Adipogenesis—IL6—melanoma	0.000133	0.00145	CbGpPWpGaD
Mometasone—CYP2C8—Metabolism of lipids and lipoproteins—CYP17A1—melanoma	0.000122	0.00133	CbGpPWpGaD
Mometasone—NR3C1—Generic Transcription Pathway—NOTCH1—melanoma	0.00012	0.00131	CbGpPWpGaD
Mometasone—NR3C1—SIDS Susceptibility Pathways—IL6—melanoma	0.000115	0.00126	CbGpPWpGaD
Mometasone—CYP2C8—Metabolism—PLCB4—melanoma	0.000115	0.00125	CbGpPWpGaD
Mometasone—NR3C1—Generic Transcription Pathway—PPARG—melanoma	0.000114	0.00124	CbGpPWpGaD
Mometasone—CYP2C8—Metabolism of lipids and lipoproteins—FASN—melanoma	0.000113	0.00123	CbGpPWpGaD
Mometasone—CYP2C8—Metabolism—SLC6A11—melanoma	0.000108	0.00118	CbGpPWpGaD
Mometasone—CYP2C8—Metabolism—PIP4K2A—melanoma	0.000108	0.00118	CbGpPWpGaD
Mometasone—CYP2C8—Metabolism—MTAP—melanoma	0.000105	0.00115	CbGpPWpGaD
Mometasone—CYP2C8—Metabolism of lipids and lipoproteins—CYP1B1—melanoma	0.000103	0.00112	CbGpPWpGaD
Mometasone—NR3C1—Gene Expression—HDAC2—melanoma	0.000101	0.0011	CbGpPWpGaD
Mometasone—CYP2C8—Metabolism—LUM—melanoma	9.38e-05	0.00102	CbGpPWpGaD
Mometasone—CYP2C8—Metabolism—PHGDH—melanoma	9.38e-05	0.00102	CbGpPWpGaD
Mometasone—CYP2C8—Metabolism—HPSE—melanoma	9.2e-05	0.001	CbGpPWpGaD
Mometasone—CYP2C8—Metabolism—CUBN—melanoma	9.03e-05	0.000984	CbGpPWpGaD
Mometasone—CYP2C8—Metabolism—SDHD—melanoma	8.72e-05	0.000951	CbGpPWpGaD
Mometasone—CYP2C8—Metabolism—CSPG4—melanoma	8.72e-05	0.000951	CbGpPWpGaD
Mometasone—CYP2C8—Metabolism—BSG—melanoma	8.72e-05	0.000951	CbGpPWpGaD
Mometasone—CYP2C8—Metabolism—GPAM—melanoma	8.44e-05	0.000921	CbGpPWpGaD
Mometasone—NR3C1—Gene Expression—CDKN2B—melanoma	8.05e-05	0.000878	CbGpPWpGaD
Mometasone—NR3C1—Gene Expression—VDR—melanoma	7.85e-05	0.000856	CbGpPWpGaD
Mometasone—NR3C1—Gene Expression—PRKCA—melanoma	7.24e-05	0.000789	CbGpPWpGaD
Mometasone—CYP2C8—Metabolism—PLA2G6—melanoma	7.18e-05	0.000783	CbGpPWpGaD
Mometasone—NR3C1—Gene Expression—ERCC2—melanoma	7.18e-05	0.000783	CbGpPWpGaD
Mometasone—NR3C1—Generic Transcription Pathway—MYC—melanoma	6.48e-05	0.000707	CbGpPWpGaD
Mometasone—CYP2C8—Metabolism—VCAN—melanoma	6.45e-05	0.000703	CbGpPWpGaD
Mometasone—CYP2C8—Metabolism of lipids and lipoproteins—PIK3CG—melanoma	6.1e-05	0.000666	CbGpPWpGaD
Mometasone—CYP2C8—Metabolism of lipids and lipoproteins—PPARG—melanoma	5.89e-05	0.000642	CbGpPWpGaD
Mometasone—NR3C1—Gene Expression—NOTCH1—melanoma	5.8e-05	0.000632	CbGpPWpGaD
Mometasone—NR3C1—Gene Expression—PPARG—melanoma	5.47e-05	0.000597	CbGpPWpGaD
Mometasone—CYP2C8—Metabolism—CYP17A1—melanoma	5.44e-05	0.000593	CbGpPWpGaD
Mometasone—CYP2C8—Metabolism of lipids and lipoproteins—PIK3CD—melanoma	5.37e-05	0.000585	CbGpPWpGaD
Mometasone—CYP2C8—Metabolism of lipids and lipoproteins—ALB—melanoma	5.3e-05	0.000578	CbGpPWpGaD
Mometasone—CYP2C8—Metabolism—GNA11—melanoma	5.14e-05	0.00056	CbGpPWpGaD
Mometasone—CYP2C8—Metabolism—FASN—melanoma	5.03e-05	0.000548	CbGpPWpGaD
Mometasone—CYP2C8—Metabolism—SLC5A5—melanoma	4.95e-05	0.000539	CbGpPWpGaD
Mometasone—CYP2C8—Metabolism—GNAQ—melanoma	4.78e-05	0.000521	CbGpPWpGaD
Mometasone—CYP2C8—Metabolism—CD44—melanoma	4.78e-05	0.000521	CbGpPWpGaD
Mometasone—CYP2C8—Metabolism of lipids and lipoproteins—PIK3CB—melanoma	4.68e-05	0.00051	CbGpPWpGaD
Mometasone—CYP2C8—Metabolism of lipids and lipoproteins—PTGS2—melanoma	4.63e-05	0.000505	CbGpPWpGaD
Mometasone—CYP2C8—Metabolism—CYP1B1—melanoma	4.58e-05	0.000499	CbGpPWpGaD
Mometasone—CYP2C8—Metabolism of lipids and lipoproteins—PTEN—melanoma	4.04e-05	0.000441	CbGpPWpGaD
Mometasone—CYP2C8—Metabolism—ABCB1—melanoma	3.77e-05	0.000411	CbGpPWpGaD
Mometasone—CYP2C8—Metabolism—PRKCA—melanoma	3.47e-05	0.000378	CbGpPWpGaD
Mometasone—CYP2C8—Metabolism—ERCC2—melanoma	3.44e-05	0.000375	CbGpPWpGaD
Mometasone—NR3C1—Gene Expression—MAPK3—melanoma	3.21e-05	0.00035	CbGpPWpGaD
Mometasone—NR3C1—Gene Expression—MYC—melanoma	3.12e-05	0.00034	CbGpPWpGaD
Mometasone—CYP2C8—Metabolism of lipids and lipoproteins—PIK3CA—melanoma	2.85e-05	0.000311	CbGpPWpGaD
Mometasone—CYP2C8—Metabolism—PIK3CG—melanoma	2.72e-05	0.000296	CbGpPWpGaD
Mometasone—CYP2C8—Metabolism—PPARG—melanoma	2.62e-05	0.000286	CbGpPWpGaD
Mometasone—CYP2C8—Metabolism—PIK3CD—melanoma	2.39e-05	0.000261	CbGpPWpGaD
Mometasone—CYP2C8—Metabolism—ALB—melanoma	2.36e-05	0.000257	CbGpPWpGaD
Mometasone—NR3C1—Gene Expression—AKT1—melanoma	2.16e-05	0.000236	CbGpPWpGaD
Mometasone—CYP2C8—Metabolism—PIK3CB—melanoma	2.08e-05	0.000227	CbGpPWpGaD
Mometasone—CYP2C8—Metabolism—PTGS2—melanoma	2.06e-05	0.000225	CbGpPWpGaD
Mometasone—CYP2C8—Metabolism—PTEN—melanoma	1.8e-05	0.000196	CbGpPWpGaD
Mometasone—CYP2C8—Metabolism—PIK3CA—melanoma	1.27e-05	0.000138	CbGpPWpGaD
Mometasone—CYP2C8—Metabolism—AKT1—melanoma	1.04e-05	0.000113	CbGpPWpGaD
